Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron

This study has been terminated.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: May 24, 2002
Last updated: July 31, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2003
  Primary Completion Date: October 2003 (Final data collection date for primary outcome measure)